Clinical Trial to Assess the Safety, Feasibility, and Efficacy of Transferring a Potentially Anti-Arthritic Cytokine Gene to Human Joints with Rheumatoid Arthritis. University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
- 1 July 1996
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (10) , 1261-1280
- https://doi.org/10.1089/hum.1996.7.10-1261
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.This publication has 19 references indexed in Scilit:
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Report to the NIH Recombinant DNA Advisory Committee on Murine Replication-Competent Retrovirus (RCR) Assays (February 17, 1993)Human Gene Therapy, 1993
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.The Journal of Experimental Medicine, 1992
- Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humansCytokine, 1992
- Recombinant human interleukin‐1 β–induced increase in levels of proteoglycans, stromelysin, and leukocytes in rabbit synovial fluidArthritis & Rheumatism, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- How important are t cells in chronic rheumatoid synovitis?Arthritis & Rheumatism, 1990
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- In vivo studies on the effects of human recombinant interleukin-1β on articular cartilageInflammation Research, 1989
- Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilageNature, 1986